Paragon Care Ltd

Healthcare AU PGC


Last update at 2024-02-22T04:31:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 20.85M 10.69M 12.33M -77.20300M 12.19M
Minority interest -2.80400M -0.51000M - - -
Net income 10.76M 6.63M 8.28M -77.26900M 8.77M
Selling general administrative 70.09M 60.12M 50.71M 53.52M 61.51M
Selling and marketing expenses 11.21M 8.70M 7.24M 5.21M 7.13M
Gross profit 126.32M 102.83M 90.31M 86.81M 95.10M
Reconciled depreciation 10.29M 7.98M 6.20M 8.05M 10.01M
Ebit 27.56M 20.99M 19.51M -4.57300M 18.15M
Ebitda 37.86M 28.97M 25.71M 3.48M 28.16M
Depreciation and amortization 10.29M 7.98M 6.20M 8.05M 10.01M
Non operating income net other - - - - -
Operating income 23.26M 13.29M 13.98M -1.43000M 18.15M
Other operating expenses 83.31M 59.53M 74.01M 3.71M 219.68M
Interest expense 5.93M 5.70M 7.17M 5.61M 5.96M
Tax provision 5.20M 3.54M 4.05M -5.60300M 3.45M
Interest income 0.38M 0.13M 0.02M 7.06M 5.95M
Net interest income -6.64000M -5.97900M -7.99400M -5.60900M -5.38400M
Extraordinary items -2.08900M - 0.00000M -5.66900M -23.24800M
Non recurring - - - - -
Other items - - - - -
Income tax expense 5.20M 3.54M 4.05M -5.60300M 3.42M
Total revenue 307.63M 247.91M 235.84M 231.69M 236.09M
Total operating expenses 102.22M 84.12M 72.86M 84.75M 78.69M
Cost of revenue 181.31M 145.08M 145.53M 144.87M 140.99M
Total other income expense net 3.39M -2.04700M 2.87M -72.39800M -5.95900M
Discontinued operations -2.08900M 0.34M 0.34M -5.66900M -23.24800M
Net income from continuing ops 15.65M 7.14M 8.28M -71.60000M 8.77M
Net income applicable to common shares 10.76M 6.63M 8.28M -77.26900M -14.38600M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 448.52M 437.03M 291.92M 292.17M 384.20M
Intangible assets 6.73M 3.36M 2.37M 0.66M 8.14M
Earning assets - - - - -
Other current assets 1.73M 9.20M 0.13M 3.56M -0.03300M
Total liab 196.56M 194.69M 170.40M 179.89M 191.88M
Total stockholder equity 242.85M 236.03M 121.52M 112.28M 192.32M
Deferred long term liab - - - - -
Other current liab 29.03M 27.52M 25.55M 41.78M 7.46M
Common stock 232.30M 228.66M 113.95M 202.72M 202.72M
Capital stock 232.30M 228.66M 113.95M 202.72M 202.72M
Retained earnings 10.10M 7.53M 8.28M -88.76600M -11.49700M
Other liab 2.59M 2.26M 0.62M 0.47M 10.54M
Good will 252.33M 241.02M 149.00M 149.00M 196.18M
Other assets 9.72M 11.31M 10.84M 14.76M 7.97M
Cash 22.60M 46.20M 33.20M 24.50M 34.22M
Cash and equivalents - - - - -
Total current liabilities 93.55M 87.38M 82.21M 84.88M 72.87M
Current deferred revenue 6.16M 10.10M 1.00M 1.71M 11.79M
Net debt 99.54M 85.06M 79.81M 90.52M 87.41M
Short term debt 21.72M 26.21M 25.44M 20.49M 13.17M
Short long term debt 17.09M 22.69M 21.59M 15.95M 9.37M
Short long term debt total 122.14M 131.26M 113.01M 115.03M 121.63M
Other stockholder equity -242.39900M -236.18400M -122.23100M -113.95200M 1.09M
Property plant equipment 44.92M 30.50M 16.50M 21.45M 33.98M
Total current assets 132.65M 150.84M 113.21M 106.31M 137.93M
Long term investments 2.17M 0.26M - - -
Net tangible assets -16.21500M -8.34900M -29.85600M -37.37900M -12.00500M
Short term investments - - - 0.00000M 0.02M
Net receivables 39.43M 42.92M 26.20M 31.57M 44.13M
Long term debt 67.60M 73.40M 80.40M 81.90M 88.32M
Inventory 63.69M 51.45M 51.58M 46.66M 51.41M
Accounts payable 36.65M 23.56M 30.22M 20.90M 40.45M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 10.55M 7.38M 7.57M -1.67100M 1.09M
Additional paid in capital - - - - -
Common stock total equity - - - 202.72M 202.72M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -167.87000M -171.10900M 0.57M
Deferred long term asset charges - - - - -
Non current assets total 315.87M 286.19M 178.71M 185.87M 246.27M
Capital lease obligations 37.45M 35.18M 11.03M 17.18M 23.94M
Long term debt total 100.42M 105.05M 87.57M 94.54M 108.46M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -31.74600M 7.07M -18.80300M 0.02M -0.00100M
Change to liabilities 3.68M -14.95700M 13.71M -27.44400M -6.98000M
Total cashflows from investing activities -31.74600M 7.07M -18.80300M -11.40300M -35.47400M
Net borrowings -15.71900M -11.44700M 0.03M -3.60300M -5.43800M
Total cash from financing activities -10.00200M -11.93000M 0.03M -3.60300M 28.15M
Change to operating activities -1.06500M -4.58700M -1.51600M 4.75M 1.59M
Net income 10.76M 6.42M 8.28M -77.26900M 8.77M
Change in cash -23.60000M 13.01M 8.69M -9.71900M -6.16800M
Begin period cash flow 46.20M 33.20M 24.50M 34.22M 40.39M
End period cash flow 22.60M 46.20M 33.20M 24.50M 34.22M
Total cash from operating activities 17.75M 19.03M 27.46M 5.29M 1.16M
Issuance of capital stock 0.42M 0.48M - - 45.20M
Depreciation 8.86M 7.73M 5.96M 7.76M 10.01M
Other cashflows from investing activities -10.70000M 11.68M -0.13400M 0.07M 0.08M
Dividends paid 7.89M 7.89M 7.89M 7.89M 8.70M
Change to inventory -12.43100M 8.29M -4.91600M 4.75M -7.44300M
Change to account receivables -1.10100M 7.40M 6.21M 11.42M 4.75M
Sale purchase of stock -0.01900M -0.01900M - 0.00000M -2.90700M
Other cashflows from financing activities 7.46M -3.52800M 0.83M 2.32M -35.47400M
Change to netincome 3.25M 7.32M -0.16300M 75.37M 20.12M
Capital expenditures 21.05M 4.61M 5.29M 7.27M 9.72M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -13.53200M 15.69M 1.29M 16.17M 0.38M
Stock based compensation 0.35M 0.85M 0.07M - -
Other non cash items -1.87200M 4.88M 13.23M 58.62M 4.38M
Free cash flow -3.29700M 14.42M 22.18M -1.97900M -9.72100M


  • Previous Close 0.20
  • Market Cap140.25M
  • Volume71230
  • P/E Ratio10.50
  • Dividend Yield5.71%
  • EBITDA28.30M
  • Revenue TTM307.63M
  • Revenue Per Share TTM0.47
  • Gross Profit TTM 125.53M
  • Diluted EPS TTM0.02


ASX : PGC announces annual results, emphasizing shareholder value with a final dividend declaration.
View all ASX announcements Click Here

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Paragon Care Ltd
0.005 2.44% 0.21 10.50 6.12 0.46 0.58 0.78 6.47
EBOS Group Ltd
0.04 0.12% 34.31 25.38 23.09 0.52 2.64 0.58 12.44
Sigma Pharmaceuticals Ltd
0.02 1.86% 1.09 110.20 97.09 0.51 3.62 0.57 29.69

Reports Covered

Stock Research & News


Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health, aged care, and veterinary markets in Australia, New Zealand, and Asia. It operates through four segments: Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides digital theatre integration, telephony, nurse call, access control, CCTV, cordless, and Wi-Fi systems; and anaesthesia masks, circuits, filters, bladder scanners, and defibrillators. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. The company was incorporated in 1994 and is based in Mt Waverley, Australia.

Paragon Care Ltd

77-97 Ricketts Road, Mt Waverley, VIC, Australia, 3149

Key Executives

Name Title Year Born
Mr. Mark Robert Hooper BBus (Acc), C.P.A., CPA, FFTP, M.A.I.C.D., MAICD Group CEO, MD & Director 1959
Mr. Stephen J. Munday Exec. Officer 1964
Mr. John Andrew Walstab Exec. Director & Exec. GM of Paragon Care Asia 1963
Ms. Josephine De Martino Chief Financial Officer NA
Ms. Melanie Jaye Leydin B.Bus, C.A., CA Joint Company Sec. 1973
Ms. Claire Newstead-Sinclair BBus, C.A., CA Joint Company Sec. NA
Mr. Michael G. Rice Group Commercial Mang. 1976
Mr. John Andrew Walstab Group CEO, MD & Executive Director 1963
Ms. Melanie Jaye Leydin B.Bus, C.A. Joint Company Secretary 1973
Ms. Claire Newstead-Sinclair BBus, C.A., CA Joint Company Secretary NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).